News for hackers. Stuff that matters.
Re:Safeway, Theranos Split After $350M Deal Fizzles by danso on Tuesday November 10, 2015 @10:18PM (#10544634)
One of the most irritating things about Theranos's defenders is their argument about how Theranos should be given lesser scrutiny because of how important and noble its mission is...that's the exact opposite of how it should be, IMO.

Using Facebook as the archetypical unjustifiably-rich-startup (not my opinion, just well-repeated), in which the goal is to lower friction between friend-network-contacts...even if FB's news feed algorithm was corrupt, users have multiple ways of assessing the quality of their experience -- including out-of-band assessments (um, hanging out with friends IRL) and being able to defriend/filter lists...

The whole point of Theranos is to reduce the friction in personal health assessment...which is a great idea regardless of noble motives...but lowering friction essentially means being able to more frequently collect and analyze data about yourself. If the assessment process is bad, then using more of the product is fundamentally terrible for the person. But the bigger problem is that it isn't easy to compare health tests...if getting an old-fashioned blood draw test was trivial, then Theranos would have no purpose in the first place. So with Theranos, the easily imaginable bad-case scenario is literally that people die because of false positives and negatives, no matter the kind motives and ambitions of Holmes.

But I have to admit...at least Theranos believes in their own product? Because if it were just snake oil, they probably would've worked out a way to not use their flawed procedures for the Safeway executives, who have much interest and motive (and money) to do comparative quality testing. (unless of course the Safeway execs conducted their own blind tests...which is obviously what they should do but obviously, not all big money executives have been that skeptical of Theranos)

Re:Safeway, Theranos Split After $350M Deal Fizzles by firebones on Tuesday November 10, 2015 @10:40PM (#10544699)
Never underestimate the collective self-delusion that can emerge in a situation like this. You have a wunderkind founder, the resident genius, who is telling everyone to believe and robotically dismissing critics--who is going to question her? You have insiders and investors who want to believe--keep your mouth shut! You have ex-employees who expressed doubt vilified. Mass willful suspension of disbelief seems much more likely.

To do something like secretly changing the procedure for the Safeway execs would require someone to openly address the elephant in the room in a culture where the elephant isn't to be discussed.

When are the insider stories about the culture going to start emerging?

Re:Safeway, Theranos Split After $350M Deal Fizzles by trhway on Tuesday November 10, 2015 @11:38PM (#10544855)
>When are the insider stories about the culture going to start emerging?

glassdoor seems to be pretty clear on that company/culture (if you skip the obvious 5 star reviews :).

Re:Safeway, Theranos Split After $350M Deal Fizzles by Pyxl101 on Tuesday November 10, 2015 @10:27PM (#10544661)
> But the bigger problem is that it isn't easy to compare health tests...

It ought to be relatively easy. I mean, not easy for the average Joe, but easy for anyone seriously interested in doing it.

Draw blood twice: once with the finger prick, and once with a regular vein draw, and then test the two samples using the different methodologies. Compare the results. Seems like a fairly trivial experiment to run and reproduce.

Re:Safeway, Theranos Split After $350M Deal Fizzles by danso on Tuesday November 10, 2015 @11:16PM (#10544804)
By "compare health tests", I'm including the process of going to the clinic, waiting for the appointment, getting blood drawn via the vein, etc. etc. Apparently that's enough of a wait time and process to discourage a non-significant number of people from even getting prescribed tests. For those of us who don't have a problem with needles and can make time for the office, easier testing may open new avenues of inquiry and awareness for our health, if testing is as easy as a needle prick.

(yes, I'm leaving out the major issue of over-diagnosis...but that's an issue all kinds of testing and medical practice has to deal with)

Re:Safeway, Theranos Split After $350M Deal Fizzles by PopeOfNope on Wednesday November 11, 2015 @12:37AM (#10545010)
> It ought to be relatively easy. ... Seems like a fairly trivial experiment to run and reproduce.

That depends on what you're testing. "Blood test" and "health test" are ridiculously ambiguous terms. Something like red blood cell counts don't vary much from day to day, but some things, like blood sugar and cortisol, vary hour to hour.